Clinical Trials Directory

Trials / Completed

CompletedNCT02295488

Determinism of the Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Currently, most of the protocols used for desensitization to Hymenoptera venoms consist of a very rapid increase in doses of venom extracts administered during the SIT in a day without systemic reaction of the patient which is not yet explained. The hypothesis is that this good tolerance is due to a rapid decrease in the response of mast cells and basophils to the allergen.. The main objective is to study basophil activation in response to the allergen during the first day of desensitization, measured by basophil activation test. The initiation of desensitization follow a protocol of rapid growth rates. The basophil activation level in the course of desensitization will be analyzed by flow cytometry after in vitro stimulation by allergen. Changes in T cell polarization is also analyzed by flow cytometry. Evolution of the expression of different proteins in blood basophils will be studied by measuring their messenger RNAs

Conditions

Interventions

TypeNameDescription
PROCEDUREbiological samplingblood intake for biological sampling during validated desensitization protocol (Alyostall®)
BIOLOGICALDesensitization protocol (Alyostall®)Validated desensitization protocol using Alyostall® performed

Timeline

Start date
2015-03-23
Primary completion
2018-04-12
Completion
2018-04-12
First posted
2014-11-20
Last updated
2019-10-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02295488. Inclusion in this directory is not an endorsement.